EPA Scoffs at Valuing Health Benefits in Air Pollution Regulations
In a significant policy shift, the Environmental Protection Agency (EPA) will no longer assign a dollar value to the health benefits derived from regulations on air pollutants. Critics argue that this change may make it easier for the agency to roll back existing regulations, potentially jeopardizing public health for millions of Americans.
Why It Matters
This development raises concerns over the potential increase in air pollution and its impact on health. Experts warn that the omission of economic assessments on health benefits could diminish the regulatory safeguards that have been established to protect vulnerable populations from the adverse effects of air quality deterioration.
Key Developments
- The EPA announced it will not value potential health benefits from regulations related to fine particles and ozone, common air pollutants.
- This policy change is included in a newly published rule that weakens existing air pollution standards for fossil fuel power plants.
- Health experts have expressed worries that the agency’s approach may lead to increased pollution levels, exacerbating health issues like asthma and cardiovascular diseases.
- Critics, including Harvard’s Mary Rice and NYU’s Richard Revesz, argue that ignoring the economic value of health benefits could facilitate further rollbacks of air quality regulations.
Full Report
Regulatory Shift
The EPA’s new rule marks a departure from years of practice wherein the agency quantified the economic benefits of its regulations, which included potential lives saved and health issues mitigated through cleaner air standards. The agency justified this shift by citing uncertainties in estimating the economic impact of pollution on health, particularly from fine particulate matter, commonly referred to as PM2.5.
Public Health Concerns
Experts in public health have expressed alarm over the implications of this policy. Mary Rice, a pulmonologist, noted the particular vulnerability of groups such as children, the elderly, and individuals with chronic respiratory conditions. The long-term effects of PM2.5 exposure have been linked to an array of serious health issues, from heightened asthma rates to increased mortality.
Economic Assessment Changes
Previously, the EPA employed methodologies to assess both the costs and benefits of its regulations, yielding high benefit-to-cost ratios that underscored the economic rationale for stringent air quality rules. However, the agency’s decision to forgo assigning monetary value to health benefits is a significant policy alteration that means health gains may no longer hold weight in cost-benefit analyses.
Implications for Future Regulations
This new stance could have ramifications for air pollution standards across various industries as the agency seeks to relax oversight. Richard Revesz pointed out that this is not an isolated instance; historical trends show previous environmental mandates under the Trump administration disregarding economic benefits in favor of industry cost savings.
Context & Previous Events
Executive orders dating back to President Reagan mandated that agencies assess both the costs and benefits of major regulations like the Clean Air Act. While the EPA has typically adhered to this guideline, the current administration appears to be modifying its approach to favor industry interests over public health considerations. This shift represents a disconnection from scientific recommendations and decades of research that underscore the health improvements linked to reduced air pollution.
